Martha Louzada

Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

Martha Louzada, Marc Carrier, Alejandro Lazo‐Langner et al. · Circulation · 2012 · 221 citations · Full text

A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)

Gwynivere A Davies, Alejandro Lazo‐Langner, Esteban Gándara et al. · Thrombosis Research · 2017 · 95 citations

Central Venous Catheter, Pulmonary Embolism, Thrombosis +10

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 44 citations

Hematological Malignancy, Oncology, Transplantation +8

Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study

Nick van Es, Martha Louzada, Marc Carrier et al. · Thrombosis Research · 2018 · 40 citations

Thrombosis, Pulmonary Embolism, Epidemiology +12

Acute Aortic Thrombosis in Patients Receiving Cisplatin-Based Chemotherapy

Dellano D. Fernandes, Martha Louzada, Carolina A. Souza et al. · Current Oncology · 2011 · 36 citations · Full text

Surgical Oncology, Acute Aortic Thrombosis, Active Cancer +16